The Patent Finder
US

Polymer Conjugates of Opioid Antagonists

US 8,349,307 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Oct 18, 2022 · High confidence

USPTO later recorded it as expired for non-payment on Feb 10, 2025.

No current holder resolved from the recorded chain.
Filed Oct 6, 2009 as application 12/574,335 · Granted Jan 8, 2013
Base term plus 192 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Oct 18, 2022
2002 2026
Clock starts
Oct 18, 2002
Term ended
Oct 18, 2022
Granted
Jan 8, 2013
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
192
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,662,365.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
17
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 192 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 18, 2002, when application 10/274,296, the earliest non-provisional in its chain, was filed (this one was filed Oct 6, 2009)Oct 18, 2022High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+192 days, USPTO patent term adjustment recordApr 28, 2023High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,662,365)capped to Oct 18, 2022High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
USPTO status recordRecorded as expired for non-payment on Feb 10, 2025, after the term endedno changeHigh confidence
Computed term endThe steps above, in orderOct 18, 2022High confidence

This family

US 7,056,500Term ended
Jun 2024
Jun 2024
US 7,786,133In force
Sep 2028
Sep 2028
US 7,662,365Term ended
Oct 2022
Oct 2022
Application 11/344,404Abandoned
not computed
not computed
Application PCT/US2007/009761PCT application
no patent term
no patent term
US 8,183,376In force
Nov 2028
Nov 2028
US 8,349,307this patent
Oct 2022
Oct 2022
US 8,067,431Term ended
Feb 2025
Feb 2025
8 of 17 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 17, 2012
Reel 28571, frame 141
Nektar TherapeuticsWells Fargo Bank, National Association, as Collateral AgentGrant of Security Interest
Mar 11, 2013
Reel 29964, frame 920
Wells Fargo Bank, National Association, as Collateral AgentNektar TherapeuticsPartial Release of Patents
Oct 6, 2015
Reel 36796, frame 562
Nektar TherapeuticsTC Lending, LLC, as Collateral AgentGrant of Security Interest in United States Patents
Oct 14, 2015
Reel 36866, frame 700
Wells Fargo Bank, National Association, as Collateral AgentNektar TherapeuticsRelease of Security Interest Recorded at Reel 28571, Frame 0141
Feb 24, 2020
Reel 51909, frame 460
Redhill Biopharma Inc.HCR Collateral Management, LLC, as Administrative AgentSecurity Interest
Apr 17, 2020
Reel 53180, frame 9
TC Lending, LLC, as Collateral AgentNektar TherapeuticsRelease of Security Interest
Jul 19, 2024
Reel 68034, frame 458
HCR Redhill SPV, LLCRedhill Biopharma Inc.; Redhill Biopharma Ltd.Release of Security Interest
Jul 19, 2024
reel/frame not recorded
HCR Redhill SPV, LLCRedhill Biopharma Inc.Release of Security Interest
Jul 19, 2024
reel/frame not recorded
HCR Redhill SPV, LLCRedhill Biopharma Ltd.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited